EPISODE · May 29, 2025 · 10 MIN
In conversation with... Caroline Robert
from Listen to The Lancet Oncology · host The Lancet
Smriti Patodia, Senior Editor of The Lancet Oncology, is joined by Professor Caroline Robert from Gustave Roussy Cancer Campus, France to discuss the EBIN trial on the use of a targeted-therapy induction regimen before treatment with immune checkpoint inhibitors in patients with metastatic melanoma with BRAFV600E or BRAFV600K mutations.
Embed this episode
NOW PLAYING
In conversation with... Caroline Robert
0:00
10:45
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Listen to The Lancet Oncology?
This episode is 10 minutes long.
When was this Listen to The Lancet Oncology episode published?
This episode was published on May 29, 2025.
Can I download this Listen to The Lancet Oncology episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!